Multiple Sclerosis Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
October 14, 2024 10:39 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Multiple Sclerosis - Pipeline...
Global CNS Therapeutics Strategic Report 2023: Market to Reach $199 Billion by 2030 - Developing Market to Drive the Market Momentum, Asia-Pacific to Exhibit Fastest Growth
November 30, 2023 05:38 ET
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global CNS Therapeutics Market to...
Global CNS Therapeutics Market to Cross $132 Billion by 2024 - Unmet Healthcare Needs for Detecting & Treating CNS Conditions Brings to Fore the Untapped Market Potential
March 22, 2022 05:53 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global CNS Therapeutics...
Insights on the CNS Therapeutics Global Market to 2025 - Featuring AbbVie, Alkermes and Allergan Among Others
April 13, 2021 08:13 ET
|
Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The global market for CNS...